MiniMed (MMED) FCF Margin (2025 - 2026)

MiniMed (MMED) posted FCF Margin of 27.0% for Q2 2026, down 851.88% on a QoQ basis from 3.59% in Q2 2025, and down 3059.0% year-over-year from 0.91% in Q2 2025.

MiniMed (MMED) FCF Margin (2025 - 2026) Analysis & Trends

MiniMed's FCF Margin history runs 2 years deep, the most recent figure standing at 27.0% for Q2 2026.

  • Quarterly FCF Margin fell 3059.0% year-over-year to 27.0% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 6.58% (changed N/A YoY) and the FY2026 annual result came in at 13.54%, down 1159.0% from the prior year.
  • FCF Margin was 27.0% for Q2 2026 at MiniMed, down from 3.59% in the prior quarter.
  • Across five years, FCF Margin topped out at 3.59% in Q2 2025 and bottomed at 27.0% in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn 127.46%
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn 2.81%
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn 23.01%
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn 23.59%
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn 17.24%
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn -27.00%
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn 22.17%
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 79.91%
9 Privia Health 3.10 Bn 2.68 Bn - -8.03%
10 Omnicell 1.89 Bn 1.65 Bn 140.36 Mn 18.01%

Historic Data

Download Data
DateValue
Apr 24, 2026 -27.00%
Apr 25, 2025 3.59%